-
1
-
-
84894067309
-
A systematic analysis of global anemia burden from 1990 to 2010
-
Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014;123(5):615-624.
-
(2014)
Blood
, vol.123
, Issue.5
, pp. 615-624
-
-
Kassebaum, N.J.1
Jasrasaria, R.2
Naghavi, M.3
-
2
-
-
84871051576
-
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
-
Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-2196.
-
(2012)
Lancet
, vol.380
, Issue.9859
, pp. 2163-2196
-
-
Vos, T.1
Flaxman, A.D.2
Naghavi, M.3
-
3
-
-
2342522079
-
Parenteral iron therapy options
-
Silverstein SB, Rodgers GM. Parenteral iron therapy options. Am J Hematol. 2004;76(1):74-78.
-
(2004)
Am J Hematol
, vol.76
, Issue.1
, pp. 74-78
-
-
Silverstein, S.B.1
Rodgers, G.M.2
-
5
-
-
0034725897
-
Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation
-
Barton JC, Barton EH, Bertoli LF, Gothard CH, Sherrer JS. Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation. Am J Med. 2000;109(1):27-32.
-
(2000)
Am J Med
, vol.109
, Issue.1
, pp. 27-32
-
-
Barton, J.C.1
Barton, E.H.2
Bertoli, L.F.3
Gothard, C.H.4
Sherrer, J.S.5
-
6
-
-
0029795844
-
The safety of intravenous iron dextran in hemodialysis patients
-
Fishbane S, Ungureanu VD, Maesaka JK, Kaupke CJ, Lim V, Wish J. The safety of intravenous iron dextran in hemodialysis patients. Am J Kidney Dis. 1996;28(4):529-534.
-
(1996)
Am J Kidney Dis
, vol.28
, Issue.4
, pp. 529-534
-
-
Fishbane, S.1
Ungureanu, V.D.2
Maesaka, J.K.3
Kaupke, C.J.4
Lim, V.5
Wish, J.6
-
7
-
-
0035057037
-
Suspected iron dextran-related adverse drug events in hemodialysis patients
-
Fletes R, Lazarus JM, Gage J, Chertow GM. Suspected iron dextran-related adverse drug events in hemodialysis patients. Am J Kidney Dis. 2001;37(4):743-749.
-
(2001)
Am J Kidney Dis
, vol.37
, Issue.4
, pp. 743-749
-
-
Fletes, R.1
Lazarus, J.M.2
Gage, J.3
Chertow, G.M.4
-
8
-
-
84857592537
-
Comparison of rates of reported adverse events associated with IV iron products in the United States
-
Bailie GR. Comparison of rates of reported adverse events associated with IV iron products in the United States. Am J Health Syst Pharm. 2012;69 (4):310-320.
-
(2012)
Am J Health Syst Pharm
, vol.69
, Issue.4
, pp. 310-320
-
-
Bailie, G.R.1
-
9
-
-
0036233761
-
Sodium ferric gluconate complex in hemodialysis patients: Adverse reactions compared to placebo and iron dextran
-
Ferrlecit Publication Committee
-
Michael B, Coyne DW, Fishbane S, et al; Ferrlecit Publication Committee. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney Int. 2002;61(5):1830-1839.
-
(2002)
Kidney Int
, vol.61
, Issue.5
, pp. 1830-1839
-
-
Michael, B.1
Coyne, D.W.2
Fishbane, S.3
-
10
-
-
0033981609
-
Parenteral iron use in the management of anemia in end-stage renal disease patients
-
Bailie GR, Johnson CA, Mason NA. Parenteral iron use in the management of anemia in end-stage renal disease patients. Am J Kidney Dis. 2000;35(1): 1-12.
-
(2000)
Am J Kidney Dis
, vol.35
, Issue.1
, pp. 1-12
-
-
Bailie, G.R.1
Johnson, C.A.2
Mason, N.A.3
-
11
-
-
0038777439
-
Safety in iron management
-
Fishbane S. Safety in iron management. Am J Kidney Dis. 2003;41(5)(suppl):18-26.
-
(2003)
Am J Kidney Dis
, vol.41
, Issue.5
, pp. 18-26
-
-
Fishbane, S.1
-
12
-
-
77956481295
-
Use of parenteral iron products and serious anaphylactic-type reactions
-
Wysowski DK, Swartz L, Borders-Hemphill BV, Goulding MR, Dormitzer C. Use of parenteral iron products and serious anaphylactic-type reactions. Am J Hematol. 2010;85(9):650-654.
-
(2011)
Am J Hematol
, vol.85
, Issue.9
, pp. 650-654
-
-
Wysowski, D.K.1
Swartz, L.2
Borders-Hemphill, B.V.3
Goulding, M.R.4
Dormitzer, C.5
-
13
-
-
54149119169
-
Safety of ferumoxytol in patients with anemia and CKD
-
Singh A, Patel T, Hertel J, Bernardo M, Kausz A, Brenner L. Safety of ferumoxytol in patients with anemia and CKD. Am J Kidney Dis. 2008;52(5):907-915.
-
(2008)
Am J Kidney Dis
, vol.52
, Issue.5
, pp. 907-915
-
-
Singh, A.1
Patel, T.2
Hertel, J.3
Bernardo, M.4
Kausz, A.5
Brenner, L.6
-
14
-
-
84886265620
-
Validation of anaphylaxis in the Food and Drug Administrations Mini-Sentinel
-
Walsh KE, Cutrona SL, Foy S, et al. Validation of anaphylaxis in the Food and Drug Administrations Mini-Sentinel. Pharmacoepidemiol Drug Saf. 2013; 22(11):1205-1213.
-
(2013)
Pharmacoepidemiol Drug Saf
, vol.22
, Issue.11
, pp. 1205-1213
-
-
Walsh, K.E.1
Cutrona, S.L.2
Foy, S.3
-
15
-
-
31944443634
-
Second symposium on the definition and management of anaphylaxis: Summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium
-
Sampson HA, Muoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006; 117(2):391-397.
-
(2006)
J Allergy Clin Immunol
, vol.117
, Issue.2
, pp. 391-397
-
-
Sampson, H.A.1
Muoz-Furlong, A.2
Campbell, R.L.3
-
17
-
-
47649122992
-
Allergy and the cardiovascular system
-
Triggiani M, Patella V, Staiano RI, Granata F, Marone G. Allergy and the cardiovascular system. Clin Exp Immunol. 2008;153(suppl 1):7-11.
-
(2008)
Clin Exp Immunol
, vol.153
, pp. 7-11
-
-
Triggiani, M.1
Patella, V.2
Staiano, R.I.3
Granata, F.4
Marone, G.5
-
19
-
-
0003729242
-
-
The CollectedWorks of JohnW. Tukey VIII. Multiple Comparisons New York, NY Chapman &Hall
-
Tukey JW. The problem of multiple comparisons. In: The CollectedWorks of JohnW. Tukey VIII. Multiple Comparisons. New York, NY: Chapman &Hall; 1953.
-
(1953)
The Problem of Multiple Comparisons
-
-
Tukey, J.W.1
-
20
-
-
79955045302
-
Clinical use of intravenous iron: Administration, efficacy, and safety
-
Auerbach M, Ballard H. Clinical use of intravenous iron: administration, efficacy, and safety. Hematology Am Soc Hematol Educ Program. 2010;2010:338-347.
-
(2011)
Hematology Am Soc Hematol Educ Program
, vol.2011
, pp. 338-347
-
-
Auerbach, M.1
Ballard, H.2
-
21
-
-
0034965685
-
A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo
-
Kosch M, Bahner U, Bettger H, Matzkies F, Teschner M, Schaefer RM. A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo. Nephrol Dial Transplant. 2001;16(6):1239-1244.
-
(2001)
Nephrol Dial Transplant
, vol.16
, Issue.6
, pp. 1239-1244
-
-
Kosch, M.1
Bahner, U.2
Bettger, H.3
Matzkies, F.4
Teschner, M.5
Schaefer, R.M.6
-
22
-
-
84904054374
-
A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD
-
Macdougall IC, Strauss WE, McLaughlin J, Li Z, Dellanna F, Hertel J. A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD. Clin J Am Soc Nephrol. 2014;9(4):705-712.
-
(2014)
Clin J Am Soc Nephrol
, vol.9
, Issue.4
, pp. 705-712
-
-
Macdougall, I.C.1
Strauss, W.E.2
McLaughlin, J.3
Li, Z.4
Dellanna, F.5
Hertel, J.6
-
23
-
-
26044476338
-
Hypersensitivity reactions and deaths associated with intravenous iron preparations
-
Bailie GR, Clark JA, Lane CE, Lane PL. Hypersensitivity reactions and deaths associated with intravenous iron preparations. Nephrol Dial Transplant. 2005;20(7):1443-1449.
-
(2005)
Nephrol Dial Transplant
, vol.20
, Issue.7
, pp. 1443-1449
-
-
Bailie, G.R.1
Clark, J.A.2
Lane, C.E.3
Lane, P.L.4
-
24
-
-
31544444964
-
Update on adverse drug events associated with parenteral iron
-
Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmn J. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant. 2006;21(2):378-382.
-
(2006)
Nephrol Dial Transplant
, vol.21
, Issue.2
, pp. 378-382
-
-
Chertow, G.M.1
Mason, P.D.2
Vaage-Nilsen, O.3
Ahlmn, J.4
-
25
-
-
0033012811
-
Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextrans
-
Faich G, Strobos J. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans. Am J Kidney Dis. 1999;33(3): 464-470.
-
(1999)
Am J Kidney Dis
, vol.33
, Issue.3
, pp. 464-470
-
-
Faich, G.1
Strobos, J.2
-
26
-
-
84879840410
-
Ferumoxytol: A silver lining in the treatment of anemia of chronic kidney disease or another dark cloud?
-
Pai AB, Garba AO. Ferumoxytol: a silver lining in the treatment of anemia of chronic kidney disease or another dark cloud? J Blood Med. 2012;3:77-85.
-
(2012)
J Blood Med
, vol.3
, pp. 77-85
-
-
Pai, A.B.1
Garba, A.O.2
-
27
-
-
84947478465
-
-
FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol Updated April 2 2015 Accessed September 13, 2015
-
FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol). http://www.fda.gov/Drugs/DrugSafety/ucm440138.htm. Updated April 2, 2015. Accessed September 13, 2015.
-
-
-
|